Breath Diagnostics, Inc.
1 known investors
Find your way into Breath Diagnostics, Inc.
Sign up to see every warm intro you have to Breath Diagnostics, Inc.
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Breath Diagnostics, Inc. team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Breath Diagnostics develops OneBreath, a non-invasive breath test that captures volatile organic compounds from a single exhale and analyzes them with microreactor chemistry and mass spectrometry to detect early-stage lung cancer. The test is aimed at at-risk patients such as smokers and is designed for use in clinics, pharmacies, and community health settings.
Investors · 1
In the news
Frequently asked questions
- What does Breath Diagnostics, Inc. do?
- Breath Diagnostics develops OneBreath, a non-invasive breath test that captures volatile organic compounds from a single exhale and analyzes them with microreactor chemistry and mass spectrometry to detect early-stage lung cancer. The test is aimed at at-risk patients such as smokers and is designed for use in clinics, pharmacies, and community health settings.
- Who are Breath Diagnostics, Inc.'s investors?
- Breath Diagnostics, Inc.'s investors include HealthXCapital.